NASDAQ:CUTR Cutera (CUTR) Stock Forecast, Price & News $5.90 -0.23 (-3.75%) (As of 12:57 PM ET) Add Compare Share Share Today's Range$5.88▼$6.2950-Day Range$6.13▼$20.0552-Week Range$5.88▼$52.89Volume185,438 shsAverage Volume753,857 shsMarket Capitalization$117.65 millionP/E RatioN/ADividend YieldN/APrice Target$29.20 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Cutera MarketRank™ ForecastAnalyst RatingHold2.20 Rating ScoreUpside/Downside394.9% Upside$29.20 Price TargetShort InterestHealthy26.18% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.58Based on 3 Articles This WeekInsider TradingAcquiring Shares$346,300 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($4.35) to ($2.46) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.97 out of 5 starsComputer And Technology Sector449th out of 599 stocksElectromedical Equipment Industry18th out of 21 stocks 3.1 Analyst's Opinion Consensus RatingCutera has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $29.20, Cutera has a forecasted upside of 394.9% from its current price of $5.90.Amount of Analyst CoverageCutera has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted26.18% of the outstanding shares of Cutera have been sold short.Short Interest Ratio / Days to CoverCutera has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in Cutera has recently decreased by 8.74%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCutera does not currently pay a dividend.Dividend GrowthCutera does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CUTR. Previous Next 2.5 News and Social Media Coverage News SentimentCutera has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cutera this week, compared to 3 articles on an average week.Search Interest7 people have searched for CUTR on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.MarketBeat Follows4 people have added Cutera to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cutera insiders have bought more of their company's stock than they have sold. Specifically, they have bought $346,300.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.10% of the stock of Cutera is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cutera are expected to grow in the coming year, from ($4.35) to ($2.46) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cutera is -1.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cutera is -1.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Cutera (NASDAQ:CUTR) StockCutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.Read More CUTR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CUTR Stock News HeadlinesSeptember 23, 2023 | americanbankingnews.comCutera, Inc. (NASDAQ:CUTR) Receives Consensus Rating of "Hold" from AnalystsSeptember 21, 2023 | americanbankingnews.comCutera, Inc. (NASDAQ:CUTR) Receives $29.20 Consensus PT from BrokeragesSeptember 29, 2023 | PressReach (Ad)This Stock's a Sleeping GiantThe stock everyone has their eye on - discover why it's the talk of the investment world. September 7, 2023 | finance.yahoo.comCutera Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO®September 1, 2023 | finance.yahoo.comCutera Reports Inducement Grants as permitted by the Nasdaq Listing RulesSeptember 1, 2023 | finance.yahoo.comTaylor Harris Bought 12% More Shares In CuteraSeptember 1, 2023 | businesswire.comCUTERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cutera, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmAugust 24, 2023 | markets.businessinsider.comCutera Names Jeff Jones COOSeptember 29, 2023 | PressReach (Ad)This Stock's a Sleeping GiantThe stock everyone has their eye on - discover why it's the talk of the investment world. August 24, 2023 | msn.comCutera gets new operations chiefAugust 24, 2023 | finance.yahoo.comCutera, Inc. Appoints Jeff Jones as Chief Operating OfficerAugust 11, 2023 | finance.yahoo.comCutera, Inc. (NASDAQ:CUTR) Analysts Are Reducing Their Forecasts For This YearAugust 8, 2023 | finance.yahoo.comCutera (CUTR) Reports Q2 Loss, Misses Revenue EstimatesAugust 1, 2023 | finance.yahoo.comPura Vida Investments, LLC Acquires Additional Shares in Cutera IncJuly 27, 2023 | msn.comCutera names Taylor Harris CEOJuly 27, 2023 | reuters.comCutera taps serial dealmaker Harris as CEO, stock price surgesJuly 27, 2023 | msn.comPiper Sandler Upgrades Cutera (CUTR)July 27, 2023 | bizjournals.comAfter board upheaval, Peninsula aesthetics company taps CEO with deep deal historyJuly 21, 2023 | finance.yahoo.comCutera, Inc. to Announce Second Quarter Results on August 8, 2023July 21, 2023 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cutera, Inc. (CUTR)July 15, 2023 | prnewswire.comCUTERA SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cutera, Inc. - CUTRJuly 8, 2023 | nasdaq.comStifel Maintains Cutera (CUTR) Buy RecommendationJuly 8, 2023 | prnewswire.comCUTERA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cutera, Inc. - CUTRJuly 1, 2023 | stockhouse.comJULY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Cutera, Inc. with Losses of $100,000 to Contact the FirmJune 26, 2023 | benzinga.comROSEN, A LONGSTANDING LAW FIRM, Encourages Cutera, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CUTRJune 21, 2023 | benzinga.comCutera, Inc. (CUTR) Equity Alert: Contact Robbins LLP for Information About Class Action Against Cutera, Inc. and Lead Plaintiff DeadlineJune 16, 2023 | benzinga.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Cutera, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CUTRSee More Headlines Receive CUTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter. Email Address CUTR Company Calendar Last Earnings8/08/2023Today9/29/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:CUTR CUSIPN/A CIK1162461 Webwww.cutera.com Phone(415) 657-5500Fax415-330-2444Employees540Year Founded1998Price Target and Rating Average Stock Price Forecast$29.20 High Stock Price Forecast$50.00 Low Stock Price Forecast$18.00 Forecasted Upside/Downside+376.3%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-82,340,000.00 Net Margins-31.08% Pretax Margin-30.19% Return on Equity-489.05% Return on Assets-16.01% Debt Debt-to-Equity RatioN/A Current Ratio3.59 Quick Ratio2.92 Sales & Book Value Annual Sales$252.40 million Price / Sales0.48 Cash FlowN/A Price / Cash FlowN/A Book Value($0.77) per share Price / Book-7.96Miscellaneous Outstanding Shares19,940,000Free Float19,525,000Market Cap$122.23 million OptionableOptionable Beta1.65 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Michael A. Karavitis Ph.D. (Age 53)Exec. VP & Chief Technology Officer Comp: $595.8kMr. Taylor C. Harris (Age 47)Pres, CEO & Director Mr. Stuart DrummondInterim Chief Financial OfficerMr. Jeffrey S. Jones (Age 67)Chief Operating Officer Mr. Charles G. Thier (Age 60)Chief Information Officer Anne WerdanDirector of Investor RelationsMore ExecutivesKey CompetitorsGigCapital5NYSE:GIAIRIDEXNASDAQ:IRIXRADCOMNASDAQ:RDCMPOET TechnologiesNASDAQ:POETOptimizeRxNASDAQ:OPRXView All CompetitorsInsiders & InstitutionsTaylor C HarrisBought 30,000 shares on 8/29/2023Total: $297,300.00 ($9.91/share)Stuart DrummondBought 5,000 shares on 8/29/2023Total: $49,000.00 ($9.80/share)Wolverine Trading LLCSold 46,800 shares on 8/23/2023Ownership: 0.000%California State Teachers Retirement SystemSold 2,228 shares on 8/21/2023Ownership: 0.089%Legato Capital Management LLCBought 10,767 shares on 8/18/2023Ownership: 0.204%View All Insider TransactionsView All Institutional Transactions CUTR Stock - Frequently Asked Questions Should I buy or sell Cutera stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CUTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CUTR, but not buy additional shares or sell existing shares. View CUTR analyst ratings or view top-rated stocks. What is Cutera's stock price forecast for 2023? 5 equities research analysts have issued 12 month price objectives for Cutera's stock. Their CUTR share price forecasts range from $18.00 to $50.00. On average, they predict the company's share price to reach $29.20 in the next twelve months. This suggests a possible upside of 376.3% from the stock's current price. View analysts price targets for CUTR or view top-rated stocks among Wall Street analysts. How have CUTR shares performed in 2023? Cutera's stock was trading at $44.22 at the start of the year. Since then, CUTR stock has decreased by 86.1% and is now trading at $6.13. View the best growth stocks for 2023 here. Are investors shorting Cutera? Cutera saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 5,220,000 shares, a decrease of 8.7% from the August 31st total of 5,720,000 shares. Based on an average daily trading volume, of 756,500 shares, the short-interest ratio is presently 6.9 days. View Cutera's Short Interest. When is Cutera's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our CUTR earnings forecast. How were Cutera's earnings last quarter? Cutera, Inc. (NASDAQ:CUTR) issued its quarterly earnings results on Tuesday, August, 8th. The medical device company reported ($1.59) EPS for the quarter, missing the consensus estimate of ($0.55) by $1.04. The medical device company earned $61.20 million during the quarter, compared to analysts' expectations of $64.93 million. Cutera had a negative net margin of 31.08% and a negative trailing twelve-month return on equity of 489.05%. The firm's quarterly revenue was down 4.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($2.53) earnings per share. What ETF holds Cutera's stock ? SPDR S&P Health Care Equipment ETF holds 517,362 shares of CUTR stock, representing 1.65% of its portfolio. What guidance has Cutera issued on next quarter's earnings? Cutera updated its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $220.00 million-$230.00 million, compared to the consensus revenue estimate of $264.05 million. What is David H. Mowry's approval rating as Cutera's CEO? 1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cutera own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO). What is Cutera's stock symbol? Cutera trades on the NASDAQ under the ticker symbol "CUTR." How do I buy shares of Cutera? Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cutera's stock price today? One share of CUTR stock can currently be purchased for approximately $6.13. How much money does Cutera make? Cutera (NASDAQ:CUTR) has a market capitalization of $122.23 million and generates $252.40 million in revenue each year. The medical device company earns $-82,340,000.00 in net income (profit) each year or ($3.87) on an earnings per share basis. How many employees does Cutera have? The company employs 540 workers across the globe. How can I contact Cutera? Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444. This page (NASDAQ:CUTR) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cutera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.